These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7808785

  • 1. [Methicillin resistant Staphylococcus aureus and glycopeptides (vancomycin, teicoplanin): in vitro selection of resistance].
    Serazin V, Mougeot C, Libert JM.
    Pathol Biol (Paris); 1994 Apr; 42(4):323-7. PubMed ID: 7808785
    [Abstract] [Full Text] [Related]

  • 2. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D, Toshkova K, Gavrilova V.
    Vutr Boles; 2000 Apr; 32(2):35-40. PubMed ID: 11227664
    [Abstract] [Full Text] [Related]

  • 3. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC, Ribou G, Masquelier B.
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [Abstract] [Full Text] [Related]

  • 4. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
    Gil M, Otth L, Wilson M, Arce E, Zaror A, Lizama V.
    Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of susceptibility of methicillin resistant Staphylococcus aureus strains to vancomycin].
    Młynarczyk G, Młynarczyk A, Meisel-Mikołajczyk F.
    Med Dosw Mikrobiol; 1995 Jan; 47(3-4):133-9. PubMed ID: 8833924
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z, Ofer O, Shmuely H.
    Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
    [Abstract] [Full Text] [Related]

  • 7. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M, Yazgi H, Aktaş E, Ayyildiz A, Parlak M.
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [Abstract] [Full Text] [Related]

  • 8. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L, Nicola L, De Vecchi E.
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [Abstract] [Full Text] [Related]

  • 9. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM, Ishag AH, Durgham SM.
    APMIS Suppl; 1988 Jun; 3():68-70. PubMed ID: 2972301
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL, Kiffer CR, Mendes CM, Nicolau DP.
    Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
    [Abstract] [Full Text] [Related]

  • 11. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S.
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [Abstract] [Full Text] [Related]

  • 12. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
    Jean-Pierre H, Rivière M, Darbas H, Boyer G.
    Pathol Biol (Paris); 1993 Jun; 41(6):531-6. PubMed ID: 8247632
    [Abstract] [Full Text] [Related]

  • 13. [Teicoplanin and vancomycin susceptibility in Staphylococcus aureus and coagulase-negative staphylococci].
    Caiaffa Filho HH, Lima Mde P, Sinto SI, Andriolo A, Mendes CM.
    Rev Assoc Med Bras (1992); 1994 Jun; 40(2):77-80. PubMed ID: 7820154
    [Abstract] [Full Text] [Related]

  • 14. [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro].
    Młynarczyk A, Młynarczyk G, Luczak M.
    Med Dosw Mikrobiol; 2005 Jun; 57(1):1-6. PubMed ID: 16130290
    [Abstract] [Full Text] [Related]

  • 15. [Prospective study of Staphylococcus aureus with reduced susceptibility to glycopeptides].
    Cantón R, Mir N, Martínez-Ferrer M, Sánchez del Saz B, Soler I, Baquero F.
    Rev Esp Quimioter; 1999 Mar; 12(1):48-53. PubMed ID: 10896469
    [Abstract] [Full Text] [Related]

  • 16. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C, Denis O, Struelens MJ.
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 18. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
    Cohen R, Barre J, Varon E.
    Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
    Lopez S, Hackbarth C, Romanò G, Trias J, Jabes D, Goldstein BP.
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.